Drugs for Motion Sickness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 92)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Histamine |
Approved, Investigational |
Phase 4,Phase 2,Phase 1,Not Applicable |
|
51-45-6, 75614-87-8 |
774
|
Synonyms:
.beta.-Imidazolyl-4-ethylamine
[3H]histamine
1avn
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1qft
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-imidazolyl)ethylamine
2-(4-Imidazolyl)ethylamine
2-[4-Imidazolyl]ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-imidazoleethylamine
4-Imidazoleethylamine
51-45-6
53290_FLUKA
5-imidazoleethylamine
5-Imidazoleethylamine
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
beta-aminoethylglyoxaline
beta-Aminoethylglyoxaline
beta-aminoethylimidazole
beta-Aminoethylimidazole
beta-aminothethylglyoxaline
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
bmse000744
BSPBio_001117
BSPBio_002124
C00388
CCRIS 6535
Ceplene
CHEBI:18295
CHEMBL90
CID774
D08040
Dihydrochloride, histamine
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
histamine
Histamine (DCF)
|
Histamine [USAN]
Histamine Base
Histamine dihydrochloride
Histamine hydrochloride
Histamine, Free Base
Histaminum
Histaminum (TN)
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Hydrochloride, histamine
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L000292
L-Histamin base
L-histamine
L-Histamine
Lopac0_000595
Lopac-H-7250
LS-75835
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
nchembio.87-comp54
nchembio714-comp1
NINDS_000308
NSC 33792
NSC33792
Peremin
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
Spectrum_000845
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
ST073926
STK346752
STOCK5S-55669
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
|
|
2 |
|
Promethazine |
Approved, Investigational |
Phase 4,Not Applicable |
|
60-87-7 |
4927
|
Synonyms:
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-dimethylamino-2-Methyl)ethyl-N-dibenzoparathiazine
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(dimethylamino)Propyl]phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4182 R.p.
4-27-00-01253 (Beilstein Handbook Reference)
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Atosil
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
Camergan
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
HMS2089E08
HSDB 3173
Hydrochloride, promethazine
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
LS-264
Metaryl
MolPort-001-783-684
N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
|
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI60_001878
NCI-C60673
N-Dimethylamino-2-methylethyl thiodiphenylamine
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
Pelpica
Phargan
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolfen
Pipolphen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Promet
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
promethazine
Promethazine
Promethazine (JAN/INN)
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
Remsed
Romergan
RP 3277
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Spectrum_000868
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
|
|
3 |
|
Diphenhydramine |
Approved, Investigational |
Phase 4,Not Applicable |
|
147-24-0, 58-73-1 |
3100
|
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-benzhydryloxy-N,N-dimethylethanamine
2-diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
a-(2-Dimethylaminoethoxy)diphenylmethane
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allermax Caplets
Aller-Med
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Amidryl
Antistominum
Antitussive
Antomin
Automin
Bagodryl
Banophen
Banophen Caplets
Baramine
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Beldin
Belix
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
BENADRYL HCl
Ben-allergin
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
Betramin
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
Citrate, diphenhydramine
Compoz
CPD-10890
D00300
Dabylen
DB01075
DB06975
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
|
Dimehydrinate
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine [INN:BAN:JAN]
Diphenhydramine Base
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine HCl
Diphenhydramine hydrochloride
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dormin
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
Histaxin
HMS2089E06
HSDB 3066
Hyadrine
Hydramine
Hydrochloride, diphenhydramine
Hyrexin
I14-6749
Ibiodral
IDI1_000368
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
Lopac0_000377
Lopac-D-3630
LS-68208
Medidryl
Mephadryl
MLS002222276
MolPort-001-783-508
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
Nausen
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
nchembio747-comp18
NCI60_002916
NCI60_022782
Nervine Nighttime Sleep-Aid
NINDS_000368
Novamina
NSC665800
Nytol Quickcaps
Nytol Quickgels
O-benzhydryldimethylaminoethanol
O-Benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
SMR001307259
SPBio_000961
SPBio_002170
Spectrum_000980
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
STK103720
STOCK2S-94461
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom Sleepgels Maximum Strength
α-(2-dimethylaminoethoxy)diphenylmethane
β-dimethylaminoethanol diphenylmethyl ether
β-dimethylaminoethyl benzhydryl ether
|
|
4 |
|
Aprepitant |
Approved, Investigational |
Phase 4 |
|
170729-80-3 |
6918365
151165
|
Synonyms:
(1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine
(2R)-(1R)-3,5-Bis(trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine
170729-80-3
221350-96-5
3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-a-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-a-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-δ(2)-1,2,4-triazolin-5-one
3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-α-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-δ(2)-1,2,4-triazolin-5-one
5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
AC1L45SL
AC1OCFCG
Aprepitant
Aprépitant
Aprepitant (JAN/USAN/INN)
Aprepitant [USAN]
Aprepitantum
CHEBI:323967
CHEBI:499361
CHEMBL135613
CHEMBL1471
CHEMBL249465
|
CID11214788
CID11318675
CID151165
CID6918365
CID9936947
CID9936948
D02968
DB00673
Emend
Emend (TN)
HMS2090N12
I06-1151
L 754030
L-754030
LS-156477
MK 0869
MK 869
MK-0517
MK-0869
MK-869
MK-869, L-754030, Emend, Aprepitant
MolPort-006-392-367
NCGC00181785-01
ONO-7436
S1189_Selleck
UNII-1NF15YR6UY
|
|
5 |
|
Ondansetron |
Approved |
Phase 4,Not Applicable |
|
99614-02-5 |
4595
|
Synonyms:
(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one
1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one
103639-04-9 (mono-hydrochloride dihydrate)
108303-49-7
116002-70-1
99614-01-4 (mono-hydrochloride)
99614-02-5
9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
AB00373674
AC1L1IIM
AKOS000599484
Apo-ondansetron
BAS 00717177
BPBio1_001118
BRD-A19736161-001-01-8
BRD-A19736161-003-03-0
BRN 3622981
BSPBio_001016
C07325
C18H19N3O
CBDivE_008994
CHEMBL46
CID4595
CPD001307702
D00456
DB00904
DESMETHYLONDANSETRON
Dihydrate, ondansetron monohydrochloride
GR 38032
GR 38032X
GR38032F
GR-38032F
HMS2090H16
Hydrochloride, ondansetron
I06-0687
I06-1329
L000456
LS-172305
LS-51878
|
MolPort-001-944-253
Monohydrochloride dihydrate, ondansetron
Monohydrochloride, ondansetron
NCI60_022780
Novo-ondansetron
ondansetron
Ondansetron (JAN/USP/INN)
ondansetron (Zofran)
Ondansetron [USAN:INN:BAN]
Ondansetron hydrochloride
Ondansetron monohydrochloride
Ondansetron monohydrochloride dihydrate
Ondansetron, (+,-)-isomer
Ondansetron, (+,-)-Isomer
Ondansetron, (R)-isomer
Ondansetron, (S)-isomer
Oprea1_435466
Oprea1_852372
PHL-ondansetron
PMS-ondansetron
Prestwick0_001058
Prestwick1_001058
Prestwick2_001058
Prestwick3_001058
Ratio-ondansetron
SAM002589958
Sandoz ondansetron
SN-307
SPBio_002938
STK370548
STOCK4S-10990
TimTec1_001750
TL8006071
UNII-4AF302ESOS
Zofran
ZOFRAN IN PLASTIC CONTAINER
Zofran odt
Zofran ODT
Zofran ODT (TN)
Zophren
Zudan
|
|
6 |
|
Fosaprepitant |
Approved |
Phase 4 |
|
172673-20-0 |
219090
|
Synonyms:
Emend for injection
Fosaprépitant
Fosaprepitant dimeglumine
|
Fosaprepitantum
L-758,298
L-758298
|
|
7 |
|
Neostigmine |
Approved, Vet_approved |
Phase 4 |
|
59-99-4 |
4456
|
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
114-80-7 (bromide)
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium
3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
51-60-5 (methyl sulfate)
59-99-4
AB00053807
AC1L1I7G
Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)
bmse000762
BPBio1_000634
BRD-K18922609-004-04-1
BRN 3615946
Bromide, neostigmine
BSPBio_000576
C07258
CAS-114-80-7
CCRIS 3079
CHEBI:7514
CID4456
D08261
DB01400
DivK1c_000165
DivK1c_000198
Eustigmin
Eustigmine
HMS2089A22
HSDB 3921
IDI1_000165
IDI1_000198
InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
Intrastigmina
Juvastigmin
KBio1_000165
KBio1_000198
KBio2_001541
KBio2_004109
KBio2_006677
KBioGR_000623
KBioSS_001541
|
Lopac0_000816
Lopac-N-2001
LS-18452
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
NCGC00015730-01
NCGC00015730-02
NCGC00015730-03
NCGC00015730-04
NCGC00015730-08
NCGC00021658-03
NCGC00163240-01
nchembio.188-comp33
Neostigmin
NEOSTIGMINE
Neostigmine (BAN)
Neostigmine [BAN]
Neostigmine bromide
Neostigmine methylsulfate
Neostigmine omega
Neostigminum
NINDS_000165
NINDS_000198
Polstigmine
Prestwick0_000468
Prestwick1_000468
Prestwick2_000468
Prestwick3_000468
Proserine
Prostigmin
Prostigmin (TN)
Prostigmine
Prozerin
SPBio_001276
SPBio_002515
Spectrum_001061
Spectrum2_001278
Spectrum4_000072
Spectrum5_001234
STL058953
sulfonatooxymethane
Synstigmin
Syntostigmine
UNII-3982TWQ96G
Vagostigmin
Vagostigmine
ZINC00001792
|
|
8 |
|
Atropine |
Approved, Vet_approved |
Phase 4 |
|
51-55-8, 5908-99-6 |
174174
|
Synonyms:
(+-)-atropine
(+-)-Atropine
(+-)-hyoscyamine
(+-)-Hyoscyamine
(+,-)-Tropyl tropate
(+,-)-Tropyl tropic acid
(+/-)-Atropine
(+/-)-Hyoscyamine
(±)-atropine
(±)-hyoscyamine
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropic acid
(3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane
(3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoic acid
120-29-6
1alphaH,5alphaH-Tropan-3alpha-ol
1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)
1alphaH,5alphaH-Tropan-3beta-ol
2-Phenylhydracrylic acid 3-alpha-tropanyl ester
51-55-8
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoic acid
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropic acid
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate
A0132_SIGMA
A2468_SIGMA
AC1L5AX3
AC1Q3XL2
ACon1_000046
AI3-60219
AKOS005137976
Ambap120-29-6
Anaspaz
Atropair
Atropen
Atropen (TN)
Atropin
Atropin [German]
Atropina
Atropina [Italian]
a-Tropine
Atropine
ATROPINE
Atropine (USP)
Atropine [BAN]
Atropine Care
Atropine sulfate
Atropine Sulfate S.O.P.
Atropin-flexiolen
atropinium cation
atropinium(1+)
Atropinol
Atropinum
Atropt
Atrosulf
b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Belladenal
Bellergal-S
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]
beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]
bmse000649
BRD-A27290375-001-01-8
|
C01479
C17H23NO3
CAS-120-29-6
CCRIS 3080
CHEBI:15742
CHEBI:15884
CHEBI:16684
CHEBI:537621
CHEBI:57858
CHEMBL1235490
CID174174
CPD001906768
Cytospaz
D00113
d1-hyoscyamine
DB00572
DB04026
dl-Hyoscyamine
DL-Hyoscyamine
DL-Tropanyl 2-hydroxy-1-phenylpropionate
DL-Tropyl tropate
dl-tropyltropate
dl-Tropyltropate
DL-Tropyltropate
DL-Tropyltropic acid
EINECS 200-104-8
endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
Eyesules
FT-0082634
HMS2089A16
HSDB 2199
hyoscyamine
Hyoscyamine sulfate
Isopto Atropine
Isopto-atropine
I-Tropine
LS-7203
MEGxp0_001878
Minims
Minims Atropine
MLS000069795
MLS001148094
MLS002695888
MolPort-001-742-593
MolPort-003-986-158
Mydriasine
NCGC00016370-01
NCGC00142514-01
NCGC00142514-03
nchembio.307-comp21
Neo-Diophen
NP-010662
Ocu-Tropine
OR22908
Protamine & Atropine
SAM002554885
SMR000058248
ST057178
ST057655
T0534
TL8000018
tropan-3alpha-ol
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate
tropan-3beta-ol
Tropanol
Tropic acid, 3-alpha-tropanyl ester
Tropic acid, ester with tropine
Tropine (+/-)-tropate
Tropine tropate
Tropine tropic acid
Tropine, tropate (ester)
Troyl tropate
Urised
|
|
9 |
|
Meclizine |
Approved |
Phase 4,Phase 2,Phase 1 |
|
569-65-3 |
4034
|
Synonyms:
(+-)-Meclizine
1-((4-Chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)piperazine
1-(p-Chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)diethylenediamine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)piperazine
1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine
1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine
1104-22-9 (di-hydrochloride)
1-p-Chlorobenzhydryl-4-m-methylbenzylpiperazine
36236-67-6 (hydrochloride)
569-65-3
AB00053493
AC1L1H9K
AC1Q2IO5
Agyrax
Ancolan
Ancolon
Antivert
Antivert/25
Antivert/50
Bonadettes
Bonadoxin
Bonamine
Bonine
BPBio1_000588
BRD-A50311610-300-05-4
BRN 0332002
BSPBio_000534
BSPBio_001949
C07116
C25H27ClN2
Calmonal
CHEMBL1623
Chiclida
CID4034
D Vert
D08163
DB00737
Diadril
Dihydrochloride, meclizine
DivK1c_000407
Dramamine
Dramamine II
DVert
D-Vert
EINECS 209-323-3
Histamethine
Histamethizine
Histametizine
Histametizyn
Histametizyne
HSDB 3113
Hydrochloride, meclizine
IDI1_000407
Itinerol
KBio1_000407
KBio2_001371
KBio2_003939
KBio2_006507
KBio3_001449
KBioGR_000473
KBioSS_001371
L001136
LS-111206
Marex
Meclicot
meclizine
Meclizine
|
Meclizine [INN:BAN]
Meclizine dihydrochloride
Meclizine Hcl
Meclizine hydrochloride
Meclizine monohydrochloride
Meclozina
Meclozina [INN-Spanish]
Meclozine
Meclozine (BAN)
Meclozinum
Meclozinum [INN-Latin]
Medivert
MolPort-002-069-043
Monamine
Monohydrochloride, meclizine
Navicalm
Neo-istafene
Neo-Istafene
Neo-suprimal
Neo-Suprimal
Neo-suprimel
Neo-Suprimel
Nevidoxine
Nevidoxine (TN)
NINDS_000407
NSC 169189
NSC169189
Parachloramine
Peremesin
Pfizer brand 1 OF meclizine dihydrochloride
Pfizer brand 2 OF meclizine dihydrochloride
Pfizer consumer healthcare brand OF meclizine dihydrochloride
Postafene
Prestwick0_000457
Prestwick1_000457
Prestwick2_000457
Prestwick3_000457
Ravelon
Roberts brand OF meclizine dihydrochloride
Ru vert m
Ru-vert-m
RuVertM
Ru-Vert-M
Sabari
Sea-Legs
Siguran
SPBio_000100
SPBio_002473
Spectrum_000891
Spectrum2_000110
Spectrum3_000485
Spectrum4_000037
Spectrum5_000919
Subari
Suprimal
Torrens brand OF meclizine dihydrochloride
Travelon
U. C. B. 5062
U.C.B. 5062
UCB 170
UCB 5052
UCB 5062
UNII-3L5TQ84570
Vedim brand OF meclizine dihydrochloride
Veritab
Vomisseis
Vomissels
WLN: T6N DNTJ AYR&R DG& D1R C1
|
|
10 |
|
Exenatide |
Approved, Investigational |
Phase 4 |
|
141758-74-9 |
15991534
|
Synonyms:
141732-76-5
141758-74-9
286014-72-0
335149-21-8
AC 2993
AC 2993 LAR
AC 2993A
Byetta
C074031
CHEBI:490990
CHEMBL414357
|
Ex4 peptide
Exenatide
Exenatide synthetic
Exenatide Synthetic
Exendin 4
Exendin 4 (Heloderma suspectum)
Exendin-4
Extendin-4
LY2148568
Synthetic exendin-4
UNII-9P1872D4OL
|
|
11 |
|
Racepinephrine |
Approved |
Phase 4 |
|
329-65-7 |
838
|
Synonyms:
(+-)-Adrenaline
(+-)-Epinephrine
2-(methylamino)-1-(3,4-Dihydroxyphenyl)ethanol
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
Bird brand OF racepinefrine hydrochloride
DL-Adrenaline
Epinephrine hydrochloride, racemic mixture
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Hydrochloride, racepinephrine
Micronefrin
|
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Vaponefrin
|
|
12 |
|
Epinephrine |
Approved, Vet_approved |
Phase 4 |
|
51-43-4 |
5816
|
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenalin
(−)-adrenaline
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(−)-adrenaline
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51028-73-0
51-43-4
51-43-4 (FREE BASE)
A0173
AC-13188
AC1L1L7B
Acetate, epinephrine
Adnephrine
ADR ADRENALINE
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalina
Adrenalina [DCIT]
adrenaline
Adrenaline
Adrénaline
Adrenaline (JP15)
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline/Epinephrine
Adrenalin-Medihaler
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
ADROP
AI3-19015
Allergan brand OF adrenaline hydrochloride
Ana-Guard
Ana-kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthmahaler Mist
Asthmanefrin
Asthma-nefrin
Astmahalin
Astminhal
Balmadren
Bernarenin
BIDD:GT0119
Biorenine
bmse000316
Bosmin
Brevirenin
Bronkaid
Bronkaid mist
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
Chelafrin
CHEMBL679
CID5816
Citanest Forte
Corisol
D00095
d-Adrenaline
DB00668
D-Epifrin
D-Epinephrine
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine acetate
Epinephrine bitartrate
Epinephrine hydrochloride
Epinephrine hydrogen tartrate
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
EPIPEN E Z PEN
Epipen EZ Pen
Epipen JR
EPIPEN JR
Epipen Jr.
|
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
HSCI1_000215
HSDB 4289
Hypernephrin
Hyporenin
Intranefrin
Iontocaine
IOP
Isoptoepinal
Kidoline
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
l-Epinephine
L-epinephrine
L-Epinephrine
l-Epinephrine (synthetic)
l-Epirenamine
L-Epirenamine
Levoadrenaline
Levoepinephrine
Levo-Methylaminoethanolcatechol
Levorenen
Levorenin
Levorenine
Levoreninum
l-Methylaminoethanolcatechol
L-Methylaminoethanolcatechol
Lopac-E-4642
LS-156
Lyodrin
Lyophrin
Medihaler-epi
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
nchembio747-comp9
Nephridine
Nieraline
NSC 62786
NSC62786
Paranephrin
PDSP1_001120
PDSP2_001104
Primatene
Primatene mist
Primatene Mist
R-(-)-Epinephrine
Racemic Epinephrine
Racepinephrine
R-Adrenaline
RCRA waste no. P042
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
Scurenaline
Septocaine
Simplene
Sindrenina
SMP1_000227
Soladren
Sphygmogenin
ST069368
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Susphrine
Sus-phrine
Sus-Phrine
SUS-PHRINE SULFITE-FREE
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
|
|
13 |
|
Substance P |
Investigational |
Phase 4 |
|
33507-63-0 |
44359816
|
Synonyms:
Arg-pro-lys-pro-GLN-GLN-phe-phe-gly-leu-met-NH2
|
|
|
14 |
|
Neurotransmitter Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
15 |
|
Histamine H1 Antagonists |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
16 |
|
Anesthetics |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
17 |
|
Histamine Antagonists |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
18 |
|
Histamine Phosphate |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
51-74-1 |
65513
|
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
|
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
|
|
19 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
20 |
|
Autonomic Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
21 |
|
Cholinergic Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
22 |
|
Muscarinic Antagonists |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
23 |
|
Scopolamine hydrobromide |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
114-49-8 |
|
24 |
|
Mydriatics |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
25 |
|
Bromides |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
26 |
|
Cholinergic Antagonists |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
27 |
|
Adjuvants, Anesthesia |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
28 |
|
Butylscopolammonium Bromide |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
29 |
|
Parasympatholytics |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
30 |
|
Central Nervous System Depressants |
|
Phase 4,Not Applicable |
|
|
|
31 |
|
Dermatologic Agents |
|
Phase 4,Not Applicable |
|
|
|
32 |
|
Anti-Allergic Agents |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
33 |
|
Anesthetics, Local |
|
Phase 4,Not Applicable |
|
|
|
34 |
|
Antiemetics |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
35 |
|
Gastrointestinal Agents |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
36 |
|
Antipruritics |
|
Phase 4,Not Applicable |
|
|
|
37 |
|
Hypnotics and Sedatives |
|
Phase 4,Not Applicable |
|
|
|
38 |
|
Psychotropic Drugs |
|
Phase 4,Not Applicable |
|
|
|
39 |
|
Anti-Anxiety Agents |
|
Phase 4,Not Applicable |
|
|
|
40 |
|
Neurokinin-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
41 |
|
Serotonin Antagonists |
|
Phase 4,Not Applicable |
|
|
|
42 |
|
Tranquilizing Agents |
|
Phase 4,Not Applicable |
|
|
|
43 |
|
Antipsychotic Agents |
|
Phase 4,Not Applicable |
|
|
|
44 |
|
neurokinin A |
|
Phase 4 |
|
|
|
45 |
|
Serotonin Agents |
|
Phase 4,Not Applicable |
|
|
|
46 |
|
Cholinesterase Inhibitors |
|
Phase 4,Not Applicable |
|
|
|
47 |
|
rGLP-1 protein |
|
Phase 4 |
|
|
|
48 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4 |
|
|
|
49 |
|
s 1 (combination) |
|
Phase 4 |
|
|
|
Synonyms:
Gimeracil / oteracil / tegafur
|
|
|
50 |
|
Epinephryl borate |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show all 50)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels |
Completed |
NCT02136420
|
Phase 4 |
Promethazine;Placebo |
2 |
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting |
Completed |
NCT01897337
|
Phase 4 |
Aprepitant;placebo |
3 |
Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting. |
Completed |
NCT02286752
|
Phase 4 |
Neostigmine;sugammadex |
4 |
Motion Sickness Medications and Vestibular Time Constant |
Recruiting |
NCT03270839
|
Phase 4 |
Bonine 25Mg Chewable Tablet;Kwells;Placebo Oral Tablet |
5 |
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness |
Not yet recruiting |
NCT03755596
|
Phase 4 |
Z. officinale extract |
6 |
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects |
Terminated |
NCT02802514
|
Phase 4 |
Albiglutide 50mg;Albiglutide matching placebo;Exenatide 10microgram;Exenatide placebo (saline) |
7 |
Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria |
Completed |
NCT00785135
|
Phase 3 |
|
8 |
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray |
Terminated |
NCT02155309
|
Phase 2, Phase 3 |
Scopolamine;Placebo |
9 |
Levo Phencynonate Hydrochloride for the Prevention of Seasickness |
Completed |
NCT02241629
|
Phase 2 |
placebo;levo phencynonate hydrochloride |
10 |
Effects of Transdermal Scopolamine on Occupational Performance |
Completed |
NCT00374478
|
Phase 2 |
Scopolamine |
11 |
Meclizine as a Potential Smoking Cessation Treatment |
Completed |
NCT01443858
|
Phase 2 |
Meclizine;Nicotine Patch;Placebo |
12 |
Phase II Dose-ranging Study of APD421 in PONV |
Completed |
NCT01510704
|
Phase 2 |
APD421;Placebo |
13 |
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV) |
Completed |
NCT00895830
|
Phase 2 |
APD405;Placebo |
14 |
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness |
Recruiting |
NCT03772340
|
Phase 2 |
Tradipitant;Placebo |
15 |
Efficacy of Ginger Extract (Compare Between the Ginger Preparation of Ancient Concept of Thai Traditional Practitioner, Standard Drug and Placebo) by Using Pain Score to Evaluate After Pain of Three Groups of First Normal Postpartum Women. |
Enrolling by invitation |
NCT03617900
|
Phase 1, Phase 2 |
Ginger;Placebo oral capsule;Paracetamol |
16 |
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine |
Withdrawn |
NCT03578354
|
Phase 2 |
4-aminopyridine;Atenolol |
17 |
A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. |
Completed |
NCT02839135
|
Phase 1 |
Reformulated scopolamine patch;Marketed scopolamine patch |
18 |
Meclizine for Hepatocellular Carcinoma |
Recruiting |
NCT03253289
|
Phase 1 |
Meclizine Oral Tablet |
19 |
Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation |
Unknown status |
NCT02986555
|
Not Applicable |
|
20 |
Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe |
Unknown status |
NCT02911402
|
|
|
21 |
A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness |
Unknown status |
NCT01198106
|
Not Applicable |
scopolamine;cinnarizine |
22 |
Parabolic Flight Induced Neuroplasticity Studied With Advanced Magnetic Resonance Imaging Methods |
Unknown status |
NCT02517216
|
Not Applicable |
|
23 |
Influence of Gravity on the Perception of Egocentric Distance (Blindpulling) |
Unknown status |
NCT02508545
|
Not Applicable |
|
24 |
Effects of Inverted Vision on Pointing and Grasping in Parabolic Flight |
Unknown status |
NCT02885844
|
Not Applicable |
|
25 |
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? |
Completed |
NCT00360282
|
Not Applicable |
Rizatriptan |
26 |
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers |
Completed |
NCT02177890
|
Not Applicable |
|
27 |
Study of Hierarchy of Afferents in Postural Control of Children With Dyslexia |
Completed |
NCT02879786
|
Not Applicable |
|
28 |
Risk Factors for Post Operative Nausea and Vomiting(PONV) in Patients Underwent Gynecological Operation Under General Anesthesia |
Completed |
NCT01020201
|
|
|
29 |
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI |
Completed |
NCT01379001
|
Not Applicable |
Scopolamine;Placebo;Donepezil |
30 |
Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia |
Completed |
NCT02416115
|
Not Applicable |
Ramosetron;Naloxone;saline;Morphine |
31 |
Virtual Reality Distraction for Procedural Pain Management and Anxiety in Children With Burn Injuries : A Pilot Study |
Completed |
NCT02794103
|
Not Applicable |
|
32 |
Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin |
Completed |
NCT00729677
|
|
|
33 |
Influence of Couch Tracking Motion |
Completed |
NCT02820532
|
Not Applicable |
|
34 |
Training Using Immersive Virtual Reality |
Completed |
NCT03721094
|
Not Applicable |
|
35 |
The Jintronix Interactive System for Upper Extremity Rehabilitation Training Post Stroke |
Completed |
NCT03759145
|
Not Applicable |
|
36 |
Evaluation of Pain and Postoperative Nausea Vomiting Incidence in Outpatient Surgery at IUCT-Oncopole Hospital |
Completed |
NCT03669328
|
|
|
37 |
Risk Factors for Postoperative Nausea, Vomiting and Pruritus |
Recruiting |
NCT03178058
|
|
|
38 |
3-dimensional Versus 2-dimensional Laparoscopy of Ovarian Cyst |
Recruiting |
NCT03453333
|
Not Applicable |
|
39 |
Virtual Reality in Labor and Delivery for Reduction in Pain |
Recruiting |
NCT03437031
|
Not Applicable |
|
40 |
Transcranial Electrical Stimulation for Mal de Debarquement Syndrome |
Recruiting |
NCT02540616
|
Not Applicable |
|
41 |
Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome |
Recruiting |
NCT02470377
|
Not Applicable |
|
42 |
The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression |
Recruiting |
NCT02849639
|
Early Phase 1 |
Scopolamine patch |
43 |
Predictive Progressive Factors of Adolescent Idiopathic Scoliosis |
Recruiting |
NCT02862392
|
|
|
44 |
Optimizing a Home-based Virtual Reality Exercise Program for Chronic Stroke Patients: A Telerehabilitation Approach |
Recruiting |
NCT03759106
|
Not Applicable |
|
45 |
Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients |
Not yet recruiting |
NCT03560583
|
Not Applicable |
Metoclopramide;Placebo Oral Tablet |
46 |
Assessment of Visual Function With a Portable Brain-computer Interface |
Not yet recruiting |
NCT03760055
|
|
|
47 |
Virtual Reality and tACS for Performance Enhancement |
Not yet recruiting |
NCT03636126
|
Not Applicable |
|
48 |
The Effect of Gum Chewing on Postoperative Ileus |
Withdrawn |
NCT00879294
|
Not Applicable |
|
49 |
Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis |
Withdrawn |
NCT02830412
|
Not Applicable |
|
50 |
Rescue Emetic Therapy for Children Having Elective Surgery |
Withdrawn |
NCT01067677
|
Not Applicable |
Metaclopramide;Ondansetron;diphenhydramine;Saline |
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
Cochrane evidence based reviews: motion sickness
|